Clinical Trial Update: A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating crisaborole ointment 2% in healthy adult Japanese subjects and adults with mild to moderate atopic dermatitis; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole Ointment (2%) (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Healthy, Atopic Dermatitis | Phase 1 | Status: COMPLETED | Results posted: 2019-03-01